PTK2 and breast cancer: We show herein that BAALC overexpressing cells exhibit significantly higher levels of p-Y397 FAK (Figure 6A), and that inhibiting FAK, but not ERK, can decrease the enhanced BAALC-mediated breast cancer cell migration (Figures 6B, C).